YOUR BUSINESS AUTHORITY
Springfield, MO
Vyera Pharmaceuticals, founded by infamous executive Martin Shkreli, reached a $40 million settlement with the Federal Trade Commission and seven states over alleged price gouging.
Shkreli founded the company as Turing Pharmaceuticals in 2015. Later that year, the company purchased the rights to Daraprim for $55 million and boosted the price to $750 per dose.
The FTC and the states are slated to proceed with a trial next week against Shkreli, who's currently in prison for a separate case involving securities and wire fraud charges.
Read more from the San Francisco Chronicle.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach